#AskDrDurie: What does it mean to be MRD-negative if you have high-risk 17p- myeloma?
In this week's video, Dr. Brian G.M. Durie discusses the implications of being MRD-negative if you have high-risk 17p- myeloma.
Testing will hopefully lead to improved therapies for patients with 17p- myeloma.
Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.